Ginkgo Tangible Asset Value from 2010 to 2026

DNA Stock  USD 8.97  0.34  3.65%   
Ginkgo Bioworks' Tangible Asset Value is steady over the years with stable fluctuation. Tangible Asset Value is expected to dwindle to 0.00. Tangible Asset Value is the total value of a company's physical, tangible assets, excluding intangible assets like patents and trademarks. View All Fundamentals
 
Tangible Asset Value  
First Reported
2010-12-31
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
0.0
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Ginkgo Bioworks financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ginkgo Bioworks' main balance sheet or income statement drivers, such as Net Interest Income of 46.5 M, Interest Income of 23 M or Depreciation And Amortization of 45.8 M, as well as many indicators such as Price To Sales Ratio of 2.45, Dividend Yield of 0.0 or PTB Ratio of 0.78. Ginkgo financial statements analysis is a perfect complement when working with Ginkgo Bioworks Valuation or Volatility modules.
  
Build AI portfolio with Ginkgo Stock
Check out the analysis of Ginkgo Bioworks Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Ginkgo Bioworks Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ginkgo Bioworks' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ginkgo Bioworks Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ginkgo Bioworks Holdings Stock:
Check out the analysis of Ginkgo Bioworks Correlation against competitors.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. Projected growth potential of Ginkgo fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Ginkgo Bioworks assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(6.18)
Revenue Per Share
3.305
Quarterly Revenue Growth
(0.56)
Return On Assets
(0.16)
Return On Equity
(0.50)
Understanding Ginkgo Bioworks Holdings requires distinguishing between market price and book value, where the latter reflects Ginkgo's accounting equity. The concept of intrinsic value—what Ginkgo Bioworks' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Ginkgo Bioworks' price substantially above or below its fundamental value.
It's important to distinguish between Ginkgo Bioworks' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Ginkgo Bioworks should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Ginkgo Bioworks' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.